Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Bristol Myers Squibb, Acceleron get FDA nod for Reblozyl to treat anaemia with lower-risk MDS

pharmaceutical-business-reviewApril 07, 2020

Tag: Bristol Myers Squibb , Acceleron Pharma , Reblozyl , MDS

PharmaSources Customer Service